Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice.

× No keyword cloud information.

19 in total

Review 1. Intravenous immunoglobulin and fibrosis.

Authors: Vered Molina; Miri Blank; Yehuda Shoenfeld
Journal: Clin Rev Allergy Immunol Date: 2005-12 Impact factor: 8.667

Review 2. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin.

Authors: Tal Sapir; Yehuda Shoenfeld
Journal: Clin Rev Allergy Immunol Date: 2005-12 Impact factor: 8.667

Review 3. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.

Authors: Marinos C Dalakas
Journal: J Neurol Date: 2006-09 Impact factor: 4.849

Review 4. Immunotherapy of systemic sclerosis.

Authors: Rebecca Manno; Francesco Boin
Journal: Immunotherapy Date: 2010-11 Impact factor: 4.196

Review 5. Recent advances in the treatment of systemic sclerosis.

Authors: Vasiliki Kalliopi K Bournia; Panayiotis G Vlachoyiannopoulos; Carlo Selmi; Haralampos M Moutsopoulos; M Eric Gershwin
Journal: Clin Rev Allergy Immunol Date: 2009-06 Impact factor: 8.667

Review 6. Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Authors: Luca Cantarini; Donato Rigante; Antonio Vitale; Salvatore Napodano; Lazaros I Sakkas; Dimitrios P Bogdanos; Yehuda Shoenfeld
Journal: Immunol Res Date: 2015-03 Impact factor: 2.829

Review 7. Cytokines in the immunopathology of systemic sclerosis.

Authors: Jasmin Raja; Christopher Paul Denton
Journal: Semin Immunopathol Date: 2015-07-08 Impact factor: 9.623

8. Immunotherapy of systemic sclerosis.

Authors: Christina G Katsiari; Theodora Simopoulou; Ioannis Alexiou; Lazaros I Sakkas
Journal: Hum Vaccin Immunother Date: 2018-07-16 Impact factor: 3.452

Review 9. Scleroderma therapy: clinical overview of current trends and future perspective.

Authors: Afsha A Topal; Rachita S Dhurat
Journal: Rheumatol Int Date: 2012-08-03 Impact factor: 2.631

Review 10. Treatment of early diffuse systemic sclerosis skin disease.

Authors: Tracy M Frech; Victoria K Shanmugam; Ami A Shah; Shervin Assassi; Jessica K Gordon; Faye N Hant; Monique E Hinchcliff; Virginia Steen; Dinesh Khanna; Cristiane Kayser; Robyn T Domsic
Journal: Clin Exp Rheumatol Date: 2013-07-23 Impact factor: 4.473